Mar 29, 2022 8:00 am EDT Volition Signs Exclusive $28 million License and Supply Agreement with Heska Corporation to Distribute Nu.Q® Vet Cancer Screening Test at the Point of Care
Mar 28, 2022 4:25 pm EDT VolitionRx Limited Schedules Full Fiscal Year 2021 Earnings Conference Call and Business Update
Jan 20, 2022 8:30 am EST Volition presents study data at ASCO GI 2022 on circulating nucleosomes for the detection of colorectal cancer and high-risk advanced adenomas
Dec 16, 2021 8:00 am EST Volition Executes its First Supply and Licensing Contract for its Nu.Q® Vet Cancer Screening Test in Asia
Nov 10, 2021 4:10 pm EST VolitionRx Limited Announces Third Quarter 2021 Financial Results and Business Update
Nov 8, 2021 8:30 am EST VolitionRx Limited Schedules Third Quarter 2021 Earnings Conference Call and Business Update
Nov 4, 2021 8:33 am EDT Volition Veterinary Presents Two Posters at the 2021 Veterinary Cancer Society Conference
Aug 11, 2021 4:10 pm EDT VolitionRx Limited Announces Second Quarter 2021 Financial Results and Business Update
Aug 4, 2021 8:15 am EDT VolitionRx Limited Schedules Second Quarter 2021 Earnings Conference Call and Business Update
Jul 22, 2021 8:00 am EDT Volition's Nu.Q® NETs Assay Demonstrates Promising Results in COVID-19 Risk Stratification and Disease Monitoring
